US3907895A - Keto-quaternary compounds - Google Patents

Keto-quaternary compounds Download PDF

Info

Publication number
US3907895A
US3907895A US445542A US44554274A US3907895A US 3907895 A US3907895 A US 3907895A US 445542 A US445542 A US 445542A US 44554274 A US44554274 A US 44554274A US 3907895 A US3907895 A US 3907895A
Authority
US
United States
Prior art keywords
compounds
keto
bromide
quaternary ammonium
quaternary compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US445542A
Inventor
Robert Andrew Bauman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US400097A external-priority patent/US3928411A/en
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Priority to US445542A priority Critical patent/US3907895A/en
Priority to CA209,689A priority patent/CA1059124A/en
Priority to GB4125174A priority patent/GB1475899A/en
Priority to DE19742450707 priority patent/DE2450707A1/en
Priority to FR7501676A priority patent/FR2272651B1/fr
Priority to US05/576,082 priority patent/US3961074A/en
Publication of US3907895A publication Critical patent/US3907895A/en
Application granted granted Critical
Priority to FR7735919A priority patent/FR2366260A1/en
Priority to FR7735918A priority patent/FR2366267A1/en
Priority to FR7735917A priority patent/FR2366261A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds

Definitions

  • the present invention relates to novel quaternary ammoniumcompounds represented by the general formula:
  • R is l-am adantyl '(C Hi R is a long chain alkyl group of l l 8 carbon atoms, 11 is an integer from 1 to 3 and X is a compatible anion such as the halides (Cl' Br, I), sulfates (i.e.. methyl sulfateynitrate. aryl sulfonates, etc.
  • the quaternary compounds possess superior anti-microbial. anti-caries and anti-calculus activity.
  • the adamantyl radical is derived from tricyclo- [3.3. l l ldeeane showing four fused chair cyelohexane rings as follows:
  • quaternary ammonium compounds which may be used in this invention are: 2adamantylearbonylethyldimethyldeeylammonium bromide. 3-adamantylcarbonylpropyldimethyltetradecylammonium bromide, Z-adamantylcarbonylethyldimethylhexadecylammonium bromide, l-adamantylearbonylethyldimethyloctadeeylammonium bromide, l-adamantylcarbonylmethyldimethyltetradecylammonium bromide, l-adamantylcarbonylmethyldimethyldodecylammonium bromide.
  • Other halides such as the chlorides, iodides and analogous compounds such as the sulfates, nitrate, aryl sulfonates, ctc.. may also be employed herein as effective anti-
  • test tube serial dilution test in which an appropriate number of test tubes of broth containing decreasing concentrations of the test agent was inoculated with the test organism. After a suitable period of incubation the tubes were examined for the presence or absence of growth. The activity of the test agent was the lowest concentration which inhibited the growth of the organism and 'is expressed as the minimal inhibitory concentration in ug/ml.
  • compounds of the instant invention When used against bacteria or fungi. compounds of the instant invention may he applied directly to the surface to be protected or may be dissolved in a pharmaceutical carrier.'Typically. an effective amount, e.g. 0.] to about-10% by weight ofthe' eompound.-is included in an inert carrier and a dispersing or. surface active agent. Alternatively. an effective amount. eg 0.] to about' l0 /z by weight may be incorporated into a solid carrier which may be inert. such as talc. clay. diatomaceous earth. flour. etc.
  • the oral preparation is a dentrifrice.
  • a dental cream. tablet or powder containing as a vehicle about 20-95% by weight of a waterinsoluble polishing material. preferably including water-insoluble phosphate such as dicalcium phosphate, tricalcium phosphate. trimagnesium phosphate.
  • the dentrifrice may also include water; binders such as glyeerine. sorbitol, propylene glycol.
  • detergents such as Irish moss and sodium carboxymethyl cellulose; additional antibacterial agents. coloring or whitening agents; preservatives; silieones; chlorophyll compounds; additional ammoniated materials; flavoring or sweetening materials; and compounds which provide fluorine-containing ion such as sodium flouride, stannous flouride and sodium monofluorophosphate.
  • the oral preparation may also be a liquid such as mouth rinse which typically contains 20-997! by weight of an aqueous lower aliphatic alcohol, preperably having about 1-3071 by weight alcohol, such as ethanol. n-propyl. or isopropyl alcohol.
  • aqueous lower aliphatic alcohol preperably having about 1-3071 by weight alcohol, such as ethanol. n-propyl. or isopropyl alcohol.
  • Such oral preparations are typically applied by brushing the teeth or rinsing the oral cavity for 30-90 seconds at least once daily.
  • Typical oral preparations of the invention which can be applied in this manner are set forth below.
  • EXAMPLE 4 The dodecyl homolog was prepared by the procedure of Example 3 yielding white crystals of melting point l40-l4l.5C and with the following analysis.
  • R is l-adamantyl.
  • R is a long chain alkyl group of 10 to 18 carbon atoms
  • n is an integer from 1 to 3.
  • X is an anion selected from the group consisting of chloride. bromide, iodide. methyl sulfate. nitrate and arylsulfonates.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel keto-quaternary ammonium compounds which include the adamantane ring system linked to the quaternary ammonium group by a keto group.

Description

United States Patent Bauman Sept. 23, 1975 KETO-QUATERNARY COMPOUNDS [56] References Cited [75] Inventor: Robert Andrew Bauman, New UNITED STATES PATENTS Brunswick, 3,565,942 2/1971 Krimmel 260/468 G 3,591,642 v7/1971 Szinai et al. [73] Asslgnee' gg f g New 3,663,617 511972 Pedrazzoli et al 260/563 P I ER P BLI A [22] Filed: Feb. 25, 1974 GT U TIONS Stepanov et aI.,- Zh. Organ. Khlm 2(4), pp. 644-648.
[21] Appl. No.: 445,542
Related U.S. Application Data Continuation-in-part of Ser. No. 400,097, Sept. 24, 1973, which is a continuation of Ser. No. 39,536, May 21, 1970, abandoned.
U.S. Cl 260/567.6 M; 424/329; 424/54;
260/501.15; 260/459 Int. Cl. C07c 87/00 Field of Search 260/567.6 M, 468 G, 584 R,
[57] ABSTRACT Novel keto-quaternary ammonium compounds which include the adamantane ring system linked to the quaternary ammonium group by a keto group.
4 Claims, No Drawings I KETO-QUATERNARY COMPOUNDS The present application is a continuation-in-part of copending application Ser. No. 400.097 filed Sept. 24. 1973, which is a continuation of patent application Ser. No. 39. 536 filed May 21. l970.'now abandoned.
The present invention relates to novel quaternary ammoniumcompounds represented by the general formula:
whereinR is l-am adantyl '(C Hi R is a long chain alkyl group of l l 8 carbon atoms, 11 is an integer from 1 to 3 and X is a compatible anion such as the halides (Cl' Br, I), sulfates (i.e.. methyl sulfateynitrate. aryl sulfonates, etc. The quaternary compounds possess superior anti-microbial. anti-caries and anti-calculus activity.
The adamantyl radical is derived from tricyclo- [3.3. l l ldeeane showing four fused chair cyelohexane rings as follows:
Typical examples of the quaternary ammonium compounds which may be used in this invention are: 2adamantylearbonylethyldimethyldeeylammonium bromide. 3-adamantylcarbonylpropyldimethyltetradecylammonium bromide, Z-adamantylcarbonylethyldimethylhexadecylammonium bromide, l-adamantylearbonylethyldimethyloctadeeylammonium bromide, l-adamantylcarbonylmethyldimethyltetradecylammonium bromide, l-adamantylcarbonylmethyldimethyldodecylammonium bromide. Other halides such as the chlorides, iodides and analogous compounds such as the sulfates, nitrate, aryl sulfonates, ctc.. may also be employed herein as effective anti-bactericides.
It has been observed that the compounds generally described by the foregoing formula are particularly effective against gram positive organisms such as Staphylococcus our-cur. Streptococcus mitis, Bacillus .s'ubti lis. Coryncbacterium acnes. and against fungi. such as Candida albicans, 'I'riclzop/zyrrm menlogrophytes and Aspergillus niger. and moderately effective against Ext-heric/n'a coli which is a gram negative bacterium. Compounds wherein R is a benzyl radical in lieu of instant higher alkyl radical would be devoid of anti-bacterial activity.
The anti-microbial nature of the instant novel compounds was shown by a standard test tube serial dilution test in which an appropriate number of test tubes of broth containing decreasing concentrations of the test agent was inoculated with the test organism. After a suitable period of incubation the tubes were examined for the presence or absence of growth. The activity of the test agent was the lowest concentration which inhibited the growth of the organism and 'is expressed as the minimal inhibitory concentration in ug/ml.
In general. smaller concentrations of the subject compounds are required to inhibit the growth of the organisms than of analogous compounds which contain substantially the'same number of carbon atoms.
When used against bacteria or fungi. compounds of the instant invention may he applied directly to the surface to be protected or may be dissolved in a pharmaceutical carrier.'Typically. an effective amount, e.g. 0.] to about-10% by weight ofthe' eompound.-is included in an inert carrier and a dispersing or. surface active agent. Alternatively. an effective amount. eg 0.] to about' l0 /z by weight may be incorporated into a solid carrier which may be inert. such as talc. clay. diatomaceous earth. flour. etc.
When compounds of the instant invention are intended for use in compositions which reduce formation of caries and inhibit formation of oral calculus. they are typically incorporated in oral preparations in effective amounts up to about 5% by weight. preferably .025] '7! and most'preferably 0.050.5'/1'by weight of the oral preparation. Typically. the oral preparation is a dentrifrice. such as a dental cream. tablet or powder. containing as a vehicle about 20-95% by weight of a waterinsoluble polishing material. preferably including water-insoluble phosphate such as dicalcium phosphate, tricalcium phosphate. trimagnesium phosphate. The dentrifrice may also include water; binders such as glyeerine. sorbitol, propylene glycol. and polyethylene glycol 400; detergents; gelling agents such as Irish moss and sodium carboxymethyl cellulose; additional antibacterial agents. coloring or whitening agents; preservatives; silieones; chlorophyll compounds; additional ammoniated materials; flavoring or sweetening materials; and compounds which provide fluorine-containing ion such as sodium flouride, stannous flouride and sodium monofluorophosphate.
The oral preparation may also be a liquid such as mouth rinse which typically contains 20-997! by weight of an aqueous lower aliphatic alcohol, preperably having about 1-3071 by weight alcohol, such as ethanol. n-propyl. or isopropyl alcohol.
Such oral preparations are typically applied by brushing the teeth or rinsing the oral cavity for 30-90 seconds at least once daily. Typical oral preparations of the invention which can be applied in this manner are set forth below.
EXAMPLE 1 Dental Cream Quaternary ammonium 0.50 adamantylkctonc *Nonionic detergent L00 Glycerine 22.00 Sodium pyrophosphate 0.25 Carboxymethyl cellulose 0.85 Sodium saccharin 0.20 Sodium henzoate 0.50 Calcium carbonate (precipitated) 5.00 Dicalcium phosphate dihydrate 46.75 Flavor 0.80 Water 2215 *Tween Polyuxyethylene (20 moles ethylene oxide) sorhitan monooleale EXAMPLE 2 !\1oulh Wash Quaternary ammonium 0.05 adamnntylketune *Nonionic detergent (Pluronic F478) 1.00 Ethyl alcohol (containing Flavor) 15.00 Gl 'eerine 10.00 Saceharin 0.02 Water 73.93
EXAMPLE 3 Preparation of l-adamantylcarbonylmethyldimethyltetradecylammonium bromide.
A mixture of 1.3g. (0.005 mole) l-adamantyl bromomethyl ketone and 1.23g. (0.005 mole) dimethyltetradecylamine was solubilized by the addition of cc acetone. The next day the solidified mixture was washed with ether and recrystallized from ethyl acetate to yield 2.1g. white crystals, m.p. l34l35.5C.
Found Calculated Carbon 67.72 (17.45
Hydrogen 10.65 10.5l
EXAMPLE 4 The dodecyl homolog was prepared by the procedure of Example 3 yielding white crystals of melting point l40-l4l.5C and with the following analysis.
Found Calculated Carbon 66.55 (16.36 Hydrogen 9.87 10.18
Although this invention has been described with reference to specific examples. it will be apparent to one skilled in the art that various modifications may be made thereto which will fall within its scope.
What is claimed is: v
1. A chemical compound having the structural formula:
wherein R is l-adamantyl. R is a long chain alkyl group of 10 to 18 carbon atoms, n is an integer from 1 to 3. and X is an anion selected from the group consisting of chloride. bromide, iodide. methyl sulfate. nitrate and arylsulfonates.
2. A chemical compound as set forth in claim 1, wherein X is a halide.
3. l-adamantanecarbonylmethyldimethyldodeeylammonium bromide.
4. l-adamantanecarbonylmethyldimethyltet-

Claims (4)

1. A CHEMICAL COMPOUND HAVING THE STRUCTURAL FORMULA.
2. A chemical compound as set forth in claim 1, wherein X is a halide.
3. 1-adamantanecarbonylmethyldimethyldodecylammonium bromide.
4. 1-adamantanecarbonylmethyldimethyltetradecylammonium bromide.
US445542A 1973-09-24 1974-02-25 Keto-quaternary compounds Expired - Lifetime US3907895A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US445542A US3907895A (en) 1973-09-24 1974-02-25 Keto-quaternary compounds
CA209,689A CA1059124A (en) 1973-09-24 1974-09-20 Quaternary compounds and oral compositions containing said compounds
GB4125174A GB1475899A (en) 1974-02-25 1974-09-23 Oral compositions containing quaternary ammonium compounds
DE19742450707 DE2450707A1 (en) 1974-02-25 1974-10-25 NEW QUATERNAERE CONNECTIONS AND THESE ORAL CARE PRODUCTS
FR7501676A FR2272651B1 (en) 1974-02-25 1975-01-20
US05/576,082 US3961074A (en) 1974-02-25 1975-05-09 Keto-quaternary compositions
FR7735919A FR2366260A1 (en) 1974-02-25 1977-11-29 IMPROVEMENT WITH QUATERNARY AMMONIUM COMPOUNDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR7735918A FR2366267A1 (en) 1974-02-25 1977-11-29 IMPROVEMENT IN QUATERNARY AMMONIUM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR7735917A FR2366261A1 (en) 1974-02-25 1977-11-29 NEW QUATERNARY AMMONIUM DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US400097A US3928411A (en) 1970-05-21 1973-09-24 New quaternary compounds having anti-microbial activity
US445542A US3907895A (en) 1973-09-24 1974-02-25 Keto-quaternary compounds
GB41256/74A GB1483508A (en) 1970-05-21 1974-09-23 Quaternary ammonium compounds and oral compositions containing them

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US400097A Continuation-In-Part US3928411A (en) 1970-05-21 1973-09-24 New quaternary compounds having anti-microbial activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US05/576,082 Division US3961074A (en) 1974-02-25 1975-05-09 Keto-quaternary compositions

Publications (1)

Publication Number Publication Date
US3907895A true US3907895A (en) 1975-09-23

Family

ID=27259694

Family Applications (1)

Application Number Title Priority Date Filing Date
US445542A Expired - Lifetime US3907895A (en) 1973-09-24 1974-02-25 Keto-quaternary compounds

Country Status (1)

Country Link
US (1) US3907895A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046873A (en) * 1973-09-24 1977-09-06 Colgate Palmolive Company Alicyclic amido-quaternary ammonium anti-bacterial agents
US4288609A (en) * 1976-11-24 1981-09-08 Rotta Research Laboratorium S.P.A. Quaternary ammonium derivatives of adamantane with antimicrobic activity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565942A (en) * 1966-06-13 1971-02-23 Searle & Co Dialkylaminoalkyl esters of adamantanecarboxylic acids
US3591642A (en) * 1966-10-24 1971-07-06 Lilly Co Eli Adamantane compounds
US3663617A (en) * 1968-10-21 1972-05-16 Rech Et D Applic Scient Et Med 1-(adamantylmethyloxy) - 2 - hydroxy-3-substituted amino propanes and acid addition salts thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565942A (en) * 1966-06-13 1971-02-23 Searle & Co Dialkylaminoalkyl esters of adamantanecarboxylic acids
US3591642A (en) * 1966-10-24 1971-07-06 Lilly Co Eli Adamantane compounds
US3663617A (en) * 1968-10-21 1972-05-16 Rech Et D Applic Scient Et Med 1-(adamantylmethyloxy) - 2 - hydroxy-3-substituted amino propanes and acid addition salts thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046873A (en) * 1973-09-24 1977-09-06 Colgate Palmolive Company Alicyclic amido-quaternary ammonium anti-bacterial agents
US4288609A (en) * 1976-11-24 1981-09-08 Rotta Research Laboratorium S.P.A. Quaternary ammonium derivatives of adamantane with antimicrobic activity

Similar Documents

Publication Publication Date Title
CA1172173A (en) Zinc derivatives and their use in mouthwash compositions
US4490353A (en) Antiplaque dentifrice with improved fluoride stability
DK167336B1 (en) AGENTS FOR ANNUAL SPIRIT
CA2151252A1 (en) Reduced alcohol mouthwash antiseptic and antiseptic preparations
US3342687A (en) Oral preparation
US3887712A (en) Oral hygiene products
US2921885A (en) Antibacterial composition
US4308253A (en) Novel oral compositions for the care of the mouth and teeth
US3907895A (en) Keto-quaternary compounds
US3928618A (en) Oral compositions
US3961074A (en) Keto-quaternary compositions
US3898284A (en) Ether-linked quaternary ammonium compounds
US3992431A (en) Quaternary compounds having anti-microbial activity
JPH08259428A (en) Oral cavity composition
US3961075A (en) Ether-linked quaternary ammonium compositions
JPH0211511A (en) Composition for oral cavity
JP4535215B2 (en) Oral composition and method for improving stabilization of ascorbic acid ester or salt thereof in oral composition
JPH09143042A (en) Composition for oral cavity
US4046873A (en) Alicyclic amido-quaternary ammonium anti-bacterial agents
JPH06239723A (en) Composition for oral cavity
US4143127A (en) Quaternary compounds having anti-microbial activity
US4123515A (en) Quaternary compounds having anti-microbial activity
US4123514A (en) Quaternary compounds having anti-microbial activity
US4123513A (en) Quaternary compounds having anti-microbial activity
US4123516A (en) Quaternary compounds having anti-microbial activity